Familial DysautonomiaSymptoms, Doctors, Treatments, Advances & More
Learn About Familial Dysautonomia
Familial dysautonomia (FD) is an inherited disorder that affects nerves throughout the body.
Riley-Day syndrome; FD; Hereditary sensory and autonomic neuropathy - type III (HSAN III); Autonomic crises - familial dysautonomia
FD is passed down through families (inherited). A person must inherit a copy of the variant gene from each parent to develop the condition.
FD occurs most often in people of Eastern European Jewish ancestry (Ashkenazi Jews). It is caused by a change to a gene. It is rare in the general population.
FD affects the nerves in the autonomic (involuntary) nervous system. These nerves manage daily body functions such as blood pressure, heart rate, sweating, bowel and bladder emptying, digestion, and the senses.
Symptoms of FD are present at birth and may grow worse over time. Symptoms vary, and may include:
- Swallowing problems in infants, resulting in aspiration pneumonia or poor growth
- Breath-holding spells, resulting in fainting
- Constipation or diarrhea
- Inability to feel pain and changes in temperature (can lead to injuries)
- Dry eyes and lack of tears when crying
- Poor coordination and unsteady walk
- Seizures
- Unusually smooth, pale tongue surface and lack of taste buds and decrease in sense of taste
After age 3, most children develop autonomic crises. These are episodes of vomiting with very high blood pressure, racing heart, fever, and sweating.
FD can't be cured. Treatment is aimed at managing the symptoms and may include:
- Medicines to help prevent seizures
- Feeding in an upright position and giving textured formula to prevent gastroesophageal reflux (stomach acid and food coming back up, also called GERD)
- Measures to prevent low blood pressure when standing, such as increasing intake of fluid, salt, and caffeine, and wearing elastic stockings
- Medicines to control vomiting
- Medicines to prevent dry eyes
- Physical therapy of the chest
- Measures to protect against injury
- Providing enough nutrition and fluids
- Surgery or spinal fusion to treat spine problems
- Treating aspiration pneumonia
BIDMC Department Of Neurology
Roy Freeman is a Neurologist practicing medicine in Boston, Massachusetts. Dr. Freeman is rated as an Elite provider by MediFind in the treatment of Familial Dysautonomia. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Orthostatic Hypotension, Familial Dysautonomia, Low Blood Pressure, and Multiple System Atrophy. Dr. Freeman is board certified in American Board Of Psychiatry And Neurology.
BIDMC Department Of Neurology
Christopher Gibbons is a Neurologist practicing medicine in Boston, Massachusetts. Dr. Gibbons is rated as an Elite provider by MediFind in the treatment of Familial Dysautonomia. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Familial Dysautonomia, Orthostatic Hypotension, Multiple System Atrophy, Osteotomy, and Knee Replacement. Dr. Gibbons is board certified in American Board Of Psychiatry And Neurology.
Brigham And Women's Faulkner Hospital, Department Of Neurology
Peter Novak is a Neurologist practicing medicine in Jamaica Plain, Massachusetts. Dr. Novak is rated as an Elite provider by MediFind in the treatment of Familial Dysautonomia. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Familial Dysautonomia, Vasoconstriction, Hereditary Sensory Neuropathy Type 1 (HSN1), Postural Orthostatic Tachycardia Syndrome (POTS), and Deep Brain Stimulation. Dr. Novak is board certified in Neurology.
Advances in diagnosis and treatment are increasing the survival rate. About one half of babies born with FD will live to age 30.
Contact your provider if symptoms change or get worse. A genetic counselor can help teach you about the condition and direct you to support groups in your area.
Genetic DNA testing is very accurate for FD. It may be used for diagnosing people with the condition or those who carry the gene. It can also be used for prenatal diagnosis.
People of Eastern European Jewish background and families with a history of FD may wish to seek genetic counseling if they are thinking of having children.
Summary: This clinical trial is designed to evaluate the safety, tolerability and preliminary efficacy of a single injection of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in patients with Multiple System Atrophy.
Summary: The primary objective of the trial is to describe the long-term safety and tolerability of TEV-56286 administered orally for the treatment of adult participants with Multiple System Atrophy (MSA). A secondary objective of the trial is to further describe the safety and tolerability of TEV-56286. The planned total duration of the trial is approximately 100 weeks.
Published Date: November 06, 2024
Published By: Anna C. Edens Hurst, MD, MS, Associate Professor in Medical Genetics, The University of Alabama at Birmingham, Birmingham, AL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Dugoff L, Wapner RJ. Prenatal diagnosis of congenital disorders. In: Lockwood CJ, Copel JA, Dugoff L, et al, eds. Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice. 9th ed. Philadelphia, PA: Elsevier; 2023:chap 30.
Ryan MM. Autonomic neuropathies. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 655.